渡口河

药物临床试验质量管理规范，Good Clinical Practice（GCP）是药物临床试验全过程的质量标准，包括方案设计、组织实施、监查、稽查、记录、分析、总结和报告。 ...

渡口河

Contents Part 4: Investigational New Drugs Responsibilities Part 5: Summary of Key Poin...

渡口河

Contents Part 1: Introduction Part 2: Phases of Clinical Trials of Investigational New ...

渡口河

Contents Part 7: Using Incentives for Study Participation Part 8: What to Do when a Par...

渡口河

Contents Part 4: Advertising for Study Participants Part 5: Retention Part 6: Retention...

渡口河

Contents Part 1: Introduction Part 2: Recruitment Part 3: Recruitment Strategies Part 1...

渡口河

Contents Part 2: Responsibilities by Role -- 2 Part 3: Summary of Key Points Part 2: Re...

渡口河

Contents Part 1: Introduction Part 2: Responsibilities by Role -- 1 Part 3: Summary of ...

渡口河

Contents Part 4: Responding to Allegations of Research Misconduct Part 5: Safeguards fo...

渡口河

Contents Part 1: Introduction Part 2: Identifying Research Misconduct Part 3: Investiga...

渡口河

Contents Part 3: Examples of Other Sponsor-Required Documens Part 4: Documenting the Us...

渡口河

Contents Part 1: Introduction Part 2: Documentation Requirements in GCP and Federal Reg...

渡口河

Contents Part 3: Trial Monitoring Activities Part 4: Summary of Key Points Part 3: Tria...

渡口河

Contents Part 1: Introduction Part 2: QA and Monitoring Role Part 1: Introduction What ...

渡口河

Contents Part 5: Adverse Event Follow-up Part 6: Summary of Key Points Part 5: Adverse ...

渡口河

Contents Part 3: Assessing an Adverse Event Part 4: Adverse Event Reporting Part 3: Ass...

渡口河

Contents Part 1: Introduction Part 2: Participant Safety & Adverse Events Part 1: Intro...

渡口河

Contents Part 8: HIPAA Rights, Privacy, and Enforcement Part 9: Summary of Key Points P...